New Delhi, Sept. 28 -- In recent years, retail participation in India's Futures and Options (F&O) segment has grown at an unprecedented pace. Data from Securities and Exchange Board of India (SEBI) re... Read More
Nigeria, Sept. 28 -- PREMIUM TIMES reporter Yakubu Muhammed has married Nafisat Brown Cisse, more than a decade after they first met on Facebook. The couple got married, turning a new chapter in thei... Read More
KUALA LUMPUR, Sept. 28 -- Tributes from across the political and social spectrum have poured in following the passing of Tun Dr Siti Hasmah Mohd Ali. Following formal condolences from the King and Qu... Read More
New Delhi, Sept. 28 -- For most students, the SAT arrives towards the end of high school, often after years of preparation and with college applications approaching. For Georgia's Ashrit Talluri, it c... Read More
Guwahati, Sept. 28 -- A study demonstrated that "female feet and legs are not simply scaled-down versions of male feet but rather differ in many shape characteristics, particularly at the arch, the la... Read More
India, Sept. 28 -- The 2026 WNBA playoffs got off to a fast-paced start Sunday, with several first-round series producing decisive Game 1 results. The Golden State Valkyries, powered by Cecilia Zandal... Read More
Singapore, Sept. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... Read More
Singapore, Sept. 28 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... Read More
Singapore, Sept. 28 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... Read More
Singapore, Sept. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ve... Read More